|
HS Code |
150013 |
| Cas Number | 2114-55-2 |
| Molecular Formula | C9H10O3 |
| Molecular Weight | 166.18 g/mol |
| Iupac Name | 1-(2,4-dihydroxyphenyl)propan-1-one |
| Appearance | White to beige crystalline powder |
| Melting Point | 85-89°C |
| Solubility In Water | Slightly soluble |
| Synonyms | 2',4'-Dihydroxypropiophenone; 2',4'-Dihydroxy-1-propiophenone |
| Pubchem Cid | 81596 |
| Smiles | CCC(=O)C1=C(C=C(C=C1)O)O |
| Inchi | InChI=1S/C9H10O3/c1-2-9(12)7-4-3-6(10)5-8(7)11/h3-5,10-11H,2H2,1H3 |
As an accredited 2',4'-Dihydroxypropiophenone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The 25g 2',4'-Dihydroxypropiophenone is supplied in an amber glass bottle with a tightly sealed screw cap for protection. |
| Shipping | 2',4'-Dihydroxypropiophenone is shipped in tightly sealed containers to prevent contamination and degradation. Store and transport it at room temperature, away from light, moisture, and incompatible substances. Follow all regulatory guidelines, including correct labeling and documentation, and comply with local, national, and international shipping regulations for chemical substances. |
| Storage | 2',4'-Dihydroxypropiophenone should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area away from sources of ignition and incompatible substances such as strong oxidizers. Protect the chemical from light, moisture, and excessive heat. Ensure it is clearly labeled and kept away from food or drink to avoid contamination and accidental ingestion. |
Applications of 2',4'-Dihydroxypropiophenone in Industrial ManufacturingOur production of 2',4'-Dihydroxypropiophenone supports specialized manufacturers as a reliable intermediate for downstream chemical synthesis. The following application scenarios highlight authentic uses across focused industry sectors, with details on compliance, formulation, integration points, and finished end products. 1. Pharmaceutical Intermediate for Non-Steroidal Anti-Inflammatory Drug SynthesisManufacturers of specialty active pharmaceutical ingredients integrate this material as a key intermediate in multistage syntheses for certain non-steroidal anti-inflammatory drugs (NSAIDs). It helps construct the core skeleton of API molecules, with process controls in place for purity and byproduct removal during reactions such as acylation or condensation, prior to subsequent functionalization. The downstream process consistently monitors the intermediate’s identity and content under GMP protocols, essential for consistent bulk production of regulated APIs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Fine Chemical Intermediate for UV-Absorber Additive ProductionThe compound functions as a building block in manufacturing certain benzophenone-based UV-absorbers, essential in coatings, plastics, and personal care formulations. Downstream plants react it in multi-step synthesis with substituents to generate highly specific stabilizers, controlling batch yields and impurity profiles for light-shielding agents in commercial products. Analytical tracing ensures every lot meets quality benchmarks for downstream melt compounding or blending processes. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Intermediate for Veterinary Drug SynthesisThis compound enters the synthesis chain for several niche veterinary APIs, addressing the need for anti-inflammatory and analgesic products in the animal health sector. Regulatory compliance requires dedicated production lines and full traceability, as requests from veterinary pharmaceutical manufacturers demand batch-specific documentation to align with national veterinary pharmacopeias and animal-use GMP procedures. Process engineers scale up controlled reactions to match target output, monitoring for carry-over and specification drift. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Chemical Intermediate for Synthesis of Flavor and Fragrance KetonesFlavors and fragrance formulators utilize this compound as a customizable ketone precursor, particularly for routes leading to aromatic-substituted acetophenone derivatives in the flavor and perfumery field. Downstream factories employ it in controlled Friedel–Crafts alkylation or acylation, adjusting molar ratios to steer reaction outcomes, followed by distillation and GC-MS analysis to ensure olfactory consistency. Compliant manufacturing must reference food additive directives and maintain alignment with international standards for trace-level impurities. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 2',4'-Dihydroxypropiophenone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Our production line for 2',4'-Dihydroxypropiophenone comes out of years standing next to reactors, solving technical problems through firsthand trials rather than theory. This molecule, with CAS number 577-60-4, draws interest from researchers and factories alike for its role as an intermediate in pharmaceutical synthesis. Often chosen for projects involving anti-inflammatory drugs and other bio-actives, its structure enables reactions that simpler phenols cannot deliver.
Before reaching drums and drums of final product, every kilogram of our 2',4'-Dihydroxypropiophenone faces our team’s scrutiny. Purity routinely tests above 99%, and our analytical chemists work every shift to nail down melting points and spectral signatures. You see only product that hits target appearance—fine white to pale yellow powder, free of grit, nothing sticky or off-odor. Moisture content and heavy metals stay well below pharmaceutical thresholds, not out of regulatory obligation but because process control matters to us.
Unlike some intermediates where plant engineers have to tweak post-processing to work around byproducts or color, ours remains clean because we control our raw material supply tight. On days when crude material starts showing hints of residue, our operators adjust the purification sequence so the customer doesn’t face problems in subsequent steps. We owned the learning curve on this one—high-throughput HPLC on every batch, not just one-in-a-dozen spot checks.
Researchers see this compound’s two hydroxyl groups and picture flexibility. In the laboratory, it often serves as a building block for more advanced molecules. Scientists use it to introduce specific ortho and para substitutions, launching a cascade of further functionalizations. In practice, our product finds its role in syntheses targeting corticosteroid side chains, as well as certain analgesic and anti-tumor agents. Formulators appreciate the well-defined melting point—between 112 and 116 degrees Celsius—which keeps reactions predictable and reduces side product formation.
Several multinational pharma companies come back to us because they’ve tried dozens of sources for this precursor. Many of those sources just buy and resell material with uncertain history. Some batches on the open market come with inconsistent crystal quality or stubborn contamination. Our clients don’t need to chase after technical support because they get us, the original manufacturer, to help with troubleshooting. Sometimes that’s adjusting solvent systems for better dissolution, and other times it means walking through analytical data together.
Plenty of chemical suppliers list 2',4'-Dihydroxypropiophenone—very few put the muscle into controlling batch consistency and traceability. Our operation runs with raw notes taken at every stage. Process history gets logged: operator names, batch temperatures, reaction times, solvent rotations, filtration throughput. Years ago, poor reproducibility sparked headaches for process chemists, especially in kilo-lab scale-ups. So we re-designed the isolation protocol, balancing crystallization temperature and solvent proportion, then kept records open to technical clients.
Our product's particulate profile sets it apart. Some competitors move material with uneven particle size; that’s not trivial if you scale up or work under GMP. We reduced fines and oversized granules by optimizing stirring and filtration—less caking, better dispersibility in downstream reactors.
Trace impurities often sabotage assay yields. Market surveys show that imported batches sometimes harbor persistent organochlorides or sulfur-trace residues. We went deep on testing input reagents and forced extra purification rounds when our TLC or GC flagged trace outliers. Instead of keeping fingers crossed, we invite buyers to walk through technical details: Karl Fischer moisture checks, UV-Vis analysis for chromophores, and even unknown peak tracking on our LC-MS systems.
The regulatory landscape changes from year to year. Several countries raised scrutiny over upstream transparency for chemical intermediates, especially those likely to end up in human health products. Our in-house compliance team reads each directive and works with plant staff directly. It isn’t about cutting corners or racing shipments—reliable product documentation stays with each batch, signed off by everyone on that night’s shift.
As synthesis projects evolve, researchers need different grades or particle sizes. We ship pharmaceutical, fine chemical, and even research-grade lots. For contract scale-ups or tech transfers, the same process engineers responsible for day-to-day plant work consult with buyers. If a customer chooses to purify further, we offer the original reaction logs so that their troubleshooting starts from real data, not assumptions.
We don’t chase every request for “just-in-time” micro-batches. Instead, we plan capacity based on actual demand signals from ongoing collaborations—chasing last-minute orders too often leads to mistakes. Our approach: keep quality stable, then scale production predictably, holding back some material as pipeline buffer to handle surprises.
Manufacturing fine chemicals and pharmaceutical intermediates involves risk every day—corrosive reagents, flammable solvents, and complex machinery never sleep. Our process safety record marks more than just zero incidents. We keep teams running regular leak checks on reactor seals, fit PPE that actually fits, and rotate tasks so no one burns out. Waste streams get pretreated before entering the main effluent lines. For this compound, we retooled one entire purification sequence to reduce solvent usage by half, even if it meant a longer process window.
Our leadership invests in cleaner production not to meet an external audit, but to keep local groundwater safe and our people healthy. Regular air quality checks run every few hours in the plant, not just at shift changes. Workers have the right to stop a process if something looks off and report issues without delay.
Some chemicals give you headaches when you move from lab-bench to production-scale. Emulsions break down, heat transfer goes sideways, and even stirring speeds throw surprises. The early days scaling 2',4'-Dihydroxypropiophenone showed us where most suppliers go wrong—neglecting foaming control, missing small shifts in solubility due to seasonal changes, or ignoring how subtle build-up in holding tanks can affect downstream purity. We learned by running small test campaigns before opening up to full batches, logging every glitched run, and iterating the protocols.
Whether bulk clients order drums or want custom packaging, we fill containers only in humidity-controlled areas to keep clumping and moisture-related degradation in check. Labels don’t just carry generic information—they track batch lineage and offer links to analytical reports. For international shipments, we support direct pre-shipment sample testing wherever possible, saving headache for those about to invest in scale-up projects.
Many of our customer questions revolve around solubility—how will this compound behave in a specific solvent system, or what’s the recommended best practice to get it into solution without hot spots or stubborn residues? We answer these questions based on results from our own plant, not borrowed textbook answers. Each plant trial adds to our internal knowledge base.
For buyers exploring new synthetic targets, we sometimes support method development by trialing different purification strategies on small lots. That can mean microfiltration tests, high-vacuum drying, or alternate crystallization solvents. If research indicates new contaminants or alternative uses, we tweak the cleanup steps and measure exactly what changes downstream. Above all, we treat every technical inquiry as an opportunity to learn and improve versus sticking to a formula.
Comparing products only by COA doesn’t show the full picture. Some samples look fine yet fail in actual process conditions—poor dissolution, off-odor, inconsistent reactivity. Our approach leans on deep process knowledge and constant improvement. Instead of aiming for good-enough, we lock in quality at each production stage. Every drum comes inspected by people who know what to look for—small hints in color, crystal habit, or subtle odor shifts. Any lot not up to our standards gets sequestered, retested, and never shipped.
Freight can sometimes go rough, especially over long summers in uncooled containers. We learned years ago to stress-test our packaging against heat and humidity spikes, backed by controlled room stability trials. If a client’s facility faces warehouse challenges, we discuss local storage conditions and suggest adjustments, based on our firsthand experience running plants through multiple climate zones.
By staying rooted at the manufacturing site—not outsourcing or operating intermediated sales—we maintain direct technical feedback and process control with minimal lag time. This means we respond quickly to clients chasing new molecular targets or battling scale-up bottlenecks. No need to wait weeks for support; usually the plant engineer responsible for your batch can field specific process advice or share original reaction logs within hours.
The future for 2',4'-Dihydroxypropiophenone stretches beyond pharmaceuticals—new research points to applications in agrochemicals and specialty fine chemicals. We keep an eye on these developments, running parallel plant trials even before formal demand arrives. Feedback from past collaborations directly shapes recipe tweaks and purification upgrades, so upcoming batches routinely surpass industry-standard test results.
Every suggestion from clients—whether it’s about particle size, appearance, or reactivity—gets taken seriously and often finds its way into process improvements. Our chemists walk both ends: they make the product and interface with buyers, closing the traditional loop that so often fails in larger organizations. Our technical staff gladly open plant logs to resolve any question, big or small.
In the chemical manufacturing world, relationships matter. We build our business not around chasing quick sales, but by ensuring every shipment reflects the depth of care and practical expertise that comes from making 2',4'-Dihydroxypropiophenone with our own hands, shift after shift, year after year.